Cargando…
RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway
BACKGROUND: Many long noncoding RNAs (lncRNAs) are the key regulators for cancer progression, including breast cancer (BC). RUSC1 antisense 1 (RUSC1‐AS1) has been found to be highly expressed in BC, but its role and potential molecular mechanism in BC remain to be further elucidated. METHODS: Quanti...
Autores principales: | Ayoufu, Aisikeer, Paierhati, Puerkaiti, Qiao, Lei, Zhang, Nan, Abudukeremu, Muzhapaer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447167/ https://www.ncbi.nlm.nih.gov/pubmed/37429610 http://dx.doi.org/10.1111/1759-7714.15035 |
Ejemplares similares
-
LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway
por: Tong, Chang-Jun, et al.
Publicado: (2021) -
HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration
por: Ayoufu, Aisikeer, et al.
Publicado: (2023) -
MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1
por: Liu, Mingxin, et al.
Publicado: (2021) -
Long-non-coding RNA RUSC1-AS1 accelerates osteosarcoma development by miR-101-3p-mediated Notch1 signalling pathway
por: Jiang, Rui, et al.
Publicado: (2021) -
MiR-326: Promising Biomarker for Cancer
por: Pan, Yao-Jie, et al.
Publicado: (2019)